Complete IPSC Stock Valuation Analysis
Comprehensive intrinsic value analysis using 2 different methodologies
IPSC DCF Analysis
IPSC (Century Therapeutics, Inc.) discounted cash flow analysis with multiple scenarios, growth assumptions, and terminal value calculations
Financial Projections
| Metrics | 2022 (Historical) | 2023 (Historical) | 2024 (Historical) | 2025 (Projected) | 2026 (Projected) | 2027 (Projected) | 2028 (Projected) | 2029 (Projected) |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.2M | $2.2M | $6.6M | $8.2M | $10.3M | $12.9M | $16.1M | $20.1M |
| Revenue Growth % | - | -57.0% | 194.8% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% |
| EBIT | $-133.8M | $-146.5M | $-138.1M | $411.8K | $514.8K | $643.5K | $804.3K | $1.0M |
| EBIT Margin % | -2574.2% | -6556.9% | -2096.5% | 5.0% | 5.0% | 5.0% | 5.0% | 5.0% |
| Tax Rate % | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% | 25.0% |
| NOPAT | $-100.4M | $-109.9M | $-103.6M | $308.9K | $386.1K | $482.6K | $603.2K | $754.1K |
| NOPAT Margin % | -1930.6% | -4917.7% | -1572.4% | 3.8% | 3.8% | 3.8% | 3.8% | 3.8% |
| Capex | $30.6M | $13.7M | $154.0K | $192.5K | $228.6K | $271.5K | $322.4K | $382.8K |
| Capex / Revenue % | 588.7% | 614.6% | 2.3% | 2.3% | 2.2% | 2.1% | 2.0% | 1.9% |
| Depreciation | $8.4M | $13.0M | $13.3M | $26.0M | $32.5M | $40.7M | $50.8M | $63.5M |
| D&A / Revenue % | 162.3% | 583.6% | 201.9% | 316.0% | 316.0% | 316.0% | 316.0% | 316.0% |
| Change in NWC | $77.4M | $-130.8M | $-94.9M | $82.4K | $103.0K | $128.7K | $160.9K | $201.1K |
| NWC Change / Revenue % | 1488.8% | -5850.4% | -1440.0% | 1.0% | 1.0% | 1.0% | 1.0% | 1.0% |
| Unlevered FCF | $-199.9M | $20.2M | $4.4M | $26.1M | $32.6M | $40.7M | $50.9M | $63.7M |
| UFCF % Chg. | - | 110.1% | -78.0% | 488.7% | 25.0% | 25.0% | 25.0% | 25.0% |
| FCF / Revenue % | -3845.8% | 901.8% | 67.2% | 316.4% | 316.5% | 316.6% | 316.7% | 316.8% |
| Discount Factor | - | - | - | 0.920 | 0.847 | 0.780 | 0.718 | 0.661 |
| Present Value of FCF | - | - | - | $24.0M | $27.6M | $31.8M | $36.6M | $42.1M |
| Sum of PV of UFCF | - | - | - | $24.0M | $51.6M | $83.4M | $119.9M | $162.0M |
WACC Calculation
Weighted Average Cost of Capital used for discounting cash flows.
| WACC Calculation | Value |
|---|---|
| Cost of Debt | 6.9% |
| Tax Rate | 25.0% |
| After Tax Cost of Debt | 5.2% |
| Risk Free Rate | 4.40% |
| Market Risk Premium | 4.3% |
| Beta | 1.77 |
| Cost of Equity | 12.1% |
| Total Debt | $53.8M |
| Market Cap | $54.2M |
| Total Capital | $108.0M |
| Debt Weighting | 49.8% |
| Equity Weighting | 50.2% |
| WACC | 8.6% |
Terminal Value
Choose between perpetuity growth or exit multiple methods.
| Terminal Value Calculation | Value |
|---|---|
| Terminal Growth Rate | 2.5% |
| Final Year FCF | $63.7M |
| Terminal Value | $1.1B |
| PV of Terminal Value | $702.6M |
| Cumulative PV of UFCF | $162.0M |
| Net Debt | $-4.6M |
| Equity Value | $869.2M |
| Shares Outstanding | 78.6M |
| Implied Share Price | $11 |
| Current Share Price | $1 |
| Implied Upside/(Downside) | +1658.1% |
Valuation Summary
$11.05
Implied Price
$0.63
Current Price
+1658.1%
Upside/Downside
8.6%
WACC
IPSC Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 9 peer companies in Healthcare
P/E Ratio
$0.00
-100.0%
Peer Median: 0.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$0.81
+29.0%
Peer Median: 0.6x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for IPSC's business model and current situation.
Multiple Comparison
| Multiple | IPSC Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -2.5x | 0.0x | 0.0x | -Infinity% | Undervalued |
| EV/EBITDA | Infinityx | 0.0x | 0.0x | Infinity% | Overvalued |
| P/S Ratio | 0.5x | 0.6x | 4.2x | -22.5% | Undervalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.04B | 0.0x | 0.0x | 2565.6x | |
| $0.06B | 0.0x | 0.0x | 0.6x | |
| $0.05B | 0.0x | 0.0x | 6.2x | |
| $0.05B | 0.0x | 0.0x | 0.5x | |
| $0.06B | 0.0x | 0.0x | 0.0x | |
| $0.05B | 0.0x | 0.0x | 0.5x | |
| $0.05B | 0.0x | 0.0x | 0.0x | |
| $0.05B | 0.0x | 0.0x | 202.9x | |
| $0.06B | 0.0x | 0.0x | 13.2x |